Screening for HIV: U.S. Preventive Services Task Force recommendation statement

Annals of Internal Medicine

Volumn 159, Issue 1, 2013, Pages 51-60

  Moyer, Virginia A ^a  

^a US Preventive Services Task Force   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

AGE DISTRIBUTION; ANAL INTERCOURSE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; COITUS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; EARLY DIAGNOSIS; EARLY INTERVENTION; HEART INFARCTION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LABOR; MALE HOMOSEXUALITY; MASS SCREENING; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANT WOMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RAPID TEST; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUALITY; SIDE EFFECT; UNITED STATES; UNSAFE SEX; UNSPECIFIED SIDE EFFECT; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; CARDIOVASCULAR DISEASES; CD4 LYMPHOCYTE COUNT; COST-BENEFIT ANALYSIS; COUNSELING; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; PREGNANCY; RISK ASSESSMENT; RISK-TAKING; YOUNG ADULT;

EID: 84878288410     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-159-1-201307020-00645     Document Type: Article

References (44)

1. Centers for Disease Control and Prevention. Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2009. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Accessed at www.cdc.gov/hiv/surveillance /resources/reports/2009report on 27 March 2013.
2. Centers for Disease Control and Prevention. Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010. Atlanta, GA: Centers for Disease Control and Prevention; 2012. Accessed at www.cdc.gov/hiv/surveillance /resources/reports/2010report on 27 March 2013.
3. Centers for Disease Control and Prevention. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data-United States and 6 U.S. Dependent Areas-2010. Atlanta, GA: Centers for Disease Control and Prevention; 2012. Accessed at www.cdc.gov/hiv/surveillance/ resources/reports/2010supp_vol17no3/index.htm on 27 March 2013.
4. Centers for Disease Control and Prevention. Estimated HIV Incidence in the United States, 2007-2010. Atlanta, GA: Centers for Disease Control and Prevention; 2012. Accessed at www.cdc.gov/hiv/surveillance/resources/reports /2010supp_vol17no4/index.htm on 27 March 2013.
5. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Owens DK; Clinical Efficacy Assessment Subcommittee, American College of Physicians. Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med. 2009;150:125-31. [PMID: 19047022]
6. Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006;145: 797-806. [PMID: 17146064]
7. Sanders GD, Bayoumi AM, Holodniy M, Owens DK. Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med. 2008; 148:889-903. [PMID: 18559840]
8. Sanders GD, Anaya HD, Asch S, Hoang T, Golden JF, Bayoumi AM, et al. Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial. J Gen Intern Med. 2010;25: 556-63. [PMID: 20204538]
9. Long EF, Brandeau ML, Owens DK. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med. 2010;153:778-89. [PMID: 21173412]
10. Centers for Disease Control and Prevention (CDC). HIV surveillance-United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60:689-93. [PMID: 21637182]
11. US Preventive Services Task Force. Screening for HIV: recommendation statement. Ann Intern Med. 2005;143:32-7. [PMID: 15998753]
12. Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med. 2010;363:257-65. [PMID: 20647201]
13. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505. [PMID: 21767103]
14. Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, et al; Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008; 197:1133-44. [PMID: 18476292]
15. Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, et al; HIVCAUSAL Collaboration. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med. 2011;154:509-15. [PMID: 21502648]
16. Ray M, Logan R, Sterne JA, Hernández-Di{dotless}́az S, Robins JM, Sabin C, et al; HIV-CAUSAL Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2010;24:123-37. [PMID: 19770621]
17. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al; NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360:1815-26. [PMID: 19339714]
18. May M, Sterne JA, Sabin C, Costagliola D, Justice AC, Thiébaut R, et al; Antiretroviral Therapy (ART) Cohort Collaboration. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS. 2007;21:1185-97. [PMID: 17502729]
19. Writing Committee for the CASCADE Collaboration. Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Arch Intern Med. 2011;171:1560-9. [PMID: 21949165]
20. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, et al; When To Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352-63. [PMID: 19361855]
21. Del Romero J, Castilla J, Hernando V, Rodri{dotless}́guez C, Garci{dotless}́a S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ. 2010;340:c2205. [PMID: 20472675]
22. Lu W, Zeng G, Luo J, Duo S, Xing G, Guo-Wei D, et al. HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China. J Acquir Immune Defic Syndr. 2010;55:232-238. [PMID: 21423851]
23. Eaton DK, Kann L, Kinchen S, Shanklin S, Flint KH, Hawkins J, et al; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance-United States, 2011. MMWRSurveill Summ. 2012;61:1-162. [PMID: 22673000]
24. Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, Schootman M, Bucholz KK, Peipert JF, et al. Age of sexual debut among US adolescents. Contraception. 2009;80:158-62. [PMID: 19631791]
25. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2010. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Accessed at www.cdc.gov/std/stats10/default.htm on 27 March 2013.
26. Garcia-Tejedor A, Maiques V, Perales A, Lopez-Aldeguer J. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission. Acta Obstet Gynecol Scand. 2009;88:882-7. [PMID: 19557554]
27. Harris NS, Fowler MG, Sansom SL, Ruffo N, Lampe MA. Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001. Am J Obstet Gynecol. 2007;197:S33-41. [PMID: 17825649]
28. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973-81. [PMID: 18453857]
29. Chou R, Korthuis PT, Huffman LH, Smits AK. Screening for Human Immunodeficiency Virus in Adolescents and Adults. Evidence synthesis no. 38. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
30. Kleinman S, Busch MP, Hall L, Thomson R, Glynn S, Gallahan D, et al. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study. JAMA. 1998;280:1080-5. [PMID: 9757856]
31. Gielen AC, O'Campo P, Faden RR, Eke A. Women's disclosure of HIV status: experiences of mistreatment and violence in an urban setting. Women Health. 1997;25:19-31. [PMID: 9273981]
32. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al; Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-8. [PMID: 20537376]
33. Reust CE. Common adverse effects of antiretroviral therapy for HIV disease. Am Fam Physician. 2011;83:1443-51. [PMID: 21671545]
34. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013:1-9. [PMID: 23459863]
35. Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003. [PMID: 14627784]
36. Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, et al; DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-35. [PMID: 17460226]
37. Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, et al; D:A:D Study Group. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration. Lancet. 2008;371:1417-26. [PMID: 18387667]
38. Rasmussen LD, Omland LH, Pedersen C, Gerstoft J, Kronborg G, Jensen J, et al. Risk of myocardial infarction in parents of HIV-infected individuals: a population-based cohort study. BMC Infect Dis. 2010;10:169. [PMID: 20546604]
39. Bedimo RJ, Westfall AO, Drechsler H, Vidiella G, Tebas P. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. Clin Infect Dis. 2011;53:84-91. [PMID: 21653308]
40. Obel N, Farkas DK, Kronborg G, Larsen CS, Pedersen G, Riis A, et al. Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study. HIV Med. 2010;11:130-6. [PMID: 19682101]
41. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al; Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17. [PMID: 16988643]
42. Lubinski C, Aberg J, Bardeguez AD, Elion R, Emmanuel P, Kuritzkes D, et al. HIV policy: the path forward-a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians. Clin Infect Dis. 2009;48:1335-44. [PMID: 19385087]
43. American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Routine human immunodeficiency virus screening. Obstet Gynecol. 2008;112:401-3. [PMID: 18669743]
44. Emmanuel PJ, Martinez J; Committee on Pediatric AIDS. Adolescents and HIV infection: the pediatrician's role in promoting routine testing. Pediatrics. 2011;128:1023-9. [PMID: 22042816]